Rational design of potent sialidase-based inhibitors of influenza virus replication

Cited by (1,001)

Items 601–700 of 1,001

1. The Use of GPCR Structures in Drug Design
   Miles Congreve, Christopher J. Langmead, Fiona H. Marshall · 2011 · Advances in pharmacology
2. Tartaric acid: a natural, green and highly efficient catalyst for the one-pot synthesis of functionalized piperidines
   Jasem Aboonajmi, Malek Taher Maghsoodlou, Nourallah Hazeri, Mojtaba Lashkari, Mehrnoosh Kangani · 2014 · Research on Chemical Intermediates
3. Use of computer in drug design and drug discovery: A review
   Md. Mofizur Rahman, Md Rezaul Karim, Md Qamrul Ahsan, Abul Bashar Ripon Khalipha, Mohammed Raihan Chowdhury, Md. Saifuzzaman · 2012 · International Journal of Pharmaceutical and Life Sciences
4. Modular pathway engineering of key carbon‐precursor supply‐pathways for improved N ‐acetylneuraminic acid production in Bacillus subtilis
   Xiaolong Zhang, Yanfeng Liu, Long Liu, Miao Wang, Jianghua Li, Guocheng Du, Jian Chen · 2018 · Biotechnology and Bioengineering
5. High-throughput virtual laboratory for drug discovery using massive datasets
   Jens Gläser, Josh V. Vermaas, David O. Williams Rogers, Jeff Larkin, Scott LeGrand, Swen Boehm, Matthew B. Baker, Aaron Scheinberg, Andreas F. Tillack, Mathialakan Thavappiragasam et al. · 2021 · The International Journal of High Performance Computing Applications
6. Enhanced Anti-influenza Agents Conjugated with Anti-inflammatory Activity
   Kung-Cheng Liu, Jim‐Min Fang, Jia‐Tsrong Jan, Ting-Jen Rachel Cheng, Shiyun Wang, Shi-Ting Yang, Yih‐Shyun E. Cheng, Chi‐Huey Wong · 2012 · Journal of Medicinal Chemistry
7. The Terminal Enzymes of Sialic Acid Metabolism: Acylneuraminate Pyruvate-Lyases
   Roland Schauer, Ulf Sommer, Dorothea Krüger, Henrieke van Unen, Christina Traving · 1999 · Bioscience Reports
8. A Single Sequence Change Destabilizes the Influenza Virus Neuraminidase Tetramer
   Joseph M. Colacino, Nickolay Y. Chirgadze, Elspeth F. Garman, K. Gopal Murti, Richard J. Loncharich, Angela J. Baxter, Kirk A. Staschke, William Graeme Laver · 1997 · Virology
9. Search for α-glucosidase inhibitors: New N-substituted valienamine and conduramine F-1 derivatives
   Robert Łysek, Catherine A. Schütz, Sylvain Favre, Anthony C. O’Sullivan, Christian Pillonel, Thomas M. Krülle, Pierre M. J. Jung, Imma Clotet‐Codina, José A. Esté, Pierre Vogel · 2006 · Bioorganic & Medicinal Chemistry
10. Synthesis and inhibitory activity of benzoic acid and pyridine derivatives on influenza neuraminidase
    Pooran Chand, Pravin L. Kotian, Philip E. Morris, Shanta Bantia, David Andrew Walsh, Yarlagadda S. Babu · 2005 · Bioorganic & Medicinal Chemistry
11. The application of experimental design to the robustness testing of a method for the determination of drug-related impurities by capillary electrophoresis
    Kevin D. Altria, S. D. Filbey · 1994 · Chromatographia
12. Synthesis and influenza neuraminidase inhibitory activity of aromatic analogues of sialic acid
    Matthew Williams, Norbert Bischofberger, Swami Swaminathan, Choung Un Kim · 1995 · Bioorganic & Medicinal Chemistry Letters
13. Cyclic Guanidino-Sugars with Low pKa as Transition-State Analog Inhibitors of Glycosidases: Neutral Instead of Charged Species Are the Active Forms
    Jin-Hyun Jeong, Brion William Murray, Shuichi Takayama, Chi‐Huey Wong · 1996 · Journal of the American Chemical Society
14. Long Time Scale GPU Dynamics Reveal the Mechanism of Drug Resistance of the Dual Mutant I223R/H275Y Neuraminidase from H1N1-2009 Influenza Virus
    Christopher J. Woods, Maturos Malaisree, Naruwan Pattarapongdilok, Pornthep Sompornpisut, Supot V. Hannongbua, Adrian John Mulholland · 2012 · Biochemistry
15. The neuraminidases of MDCK grown human influenza A(H3N2) viruses isolated since 1994 can demonstrate receptor binding
    Peter G. Mohr, Yi‐Mo Deng, Jennifer L. McKimm‐Breschkin · 2015 · Virology Journal
16. Carbohydrate Mimetics and Scaffolds: Sweet Spots in Medicinal Chemistry
    Laura Cipolla, Barbara La Ferla, Cristina Airoldi, Cristiano Zona, Alexandre Orsato, Nasrin I. Shaikh, Laura Russo, Francesco Nicotra · 2010 · Future Medicinal Chemistry
17. A Throat Lozenge Containing Amyl Meta Cresol and Dichlorobenzyl Alcohol Has a Direct Virucidal Effect on Respiratory Syncytial Virus, Influenza a and SARS-CoV
    JOHN S. OXFORD, Rob Lambkin‐Williams, Iain Gibb, Shobana Balasingam, Charlotte Chan, Andrew P. Catchpole · 2005 · Antiviral chemistry & chemotherapy
18. Serendipitous Discovery of a Potent Influenza Virus A Neuraminidase Inhibitor
    Sankar Mohan, Philip S. Kerry, Nicole Bance, Masahiro Niikura, Bernardine M. Pinto · 2013 · Angewandte Chemie International Edition
19. Combinatorial Effect of Two Framework Mutations (E119V and I222L) in the Neuraminidase Active Site of H3N2 Influenza Virus on Resistance to Oseltamivir
    Mathilde Richard, Olivier Ferraris, Alexandra Erny, Mendy Barthélémy, Aurélien Traversier, Murielle Sabatier, Alan J Hay, Yi Pu Lin, Rupert J. M. Russell, Bruno Lina · 2011 · Antimicrobial Agents and Chemotherapy
20. Green and Convenient One-Pot Access to Polyfunctionalized Piperidine ScaffoldsviaGlutamic Acid Catalyzed Knoevenagel- Intramolecular [4+2] aza-Diels-Alder Imin-Based Multi-Component Reaction Under Ambient Temperature
    Farzaneh Mohamadpour · 2018 · Polycyclic aromatic compounds
21. Passivity-Based Inverse Optimal Impulsive Control for Influenza Treatment in the Host
    Gustavo Hernández-Mejía, Alma Y. Alanís, Miguel Hernandez‐Gonzalez, Rolf Findeisen, Esteban Abelardo Hernandez-Vargas · 2019 · IEEE Transactions on Control Systems Technology
22. Diversity of sialidases found in the human body – A review
    Sabina Lipničanová, Daniela Chmelová, Miroslav Ondrejovič, Vladimı́r Frecer, Stanislav Miertuš · 2020 · International Journal of Biological Macromolecules
23. A point mutation in influenza B neuraminidase confers resistance to peramivir and loss of slow binding
    Ellen Z. Baum, Pamela C. Wagaman, Linh Ly, Ignatius J. Turchi, Jianhua Le, Doris J. Bucher, Karen Bush · 2003 · Antiviral Research
24. The potential impact of structural genomics on tuberculosis drug discovery
    Vickery L. Arcus, J. Shaun Lott, Jodie M. Johnston, Edward N. Baker · 2006 · Drug Discovery Today
25. Transition-State Mimicry by Glycosidase Inhibitors: A Critical Kinetic Analysis
    Jacqueline Wicki, Spencer John Williams, Stephen G. Withers · 2007 · Journal of the American Chemical Society
26. Pandemic influenza: its origin and control
    Graeme W. Laver, Elspeth F. Garman · 2002 · Microbes and Infection
27. Novel α- and β-Amino Acid Inhibitors of Influenza Virus Neuraminidase
    Warren M. Kati, Debra Montgomery, Clarence J. Maring, Vincent S. Stoll, Vincent L. Giranda, Xiaoqi Chen, William Graeme Laver, William E. Kohlbrenner, Daniel W. Norbeck · 2001 · Antimicrobial Agents and Chemotherapy
28. Safety and Efficacy of the Neuraminidase Inhibitor Zanamivir in Treating Influenza Virus Infection in Adults: Results from Japan
    Keizo Matsumoto, Nobuya Ogawa, K. Nerome, Yoshio Numazaki, Yoshikazu Kawakami, Kunio Shirato, Masaaki Arakawa, Shoji Kudoh, Kaoru Shimokata, Shigenori Nakajima et al. · 1999 · Antiviral Therapy
29. Improved Enzymatic Procedure for a Preparative-Scale Synthesis of Sialic Acid and KDN
    Takeshi Sugai, Atsuhito Kuboki, Shigeki Hiramatsu, Hanako Okazaki, Hiromichi Ohta · 1995 · Bulletin of the Chemical Society of Japan
30. Influenza polymerase inhibitor resistance: Assessment of the current state of the art - A report of the isirv Antiviral group
    Michael G. Ison, Frederick G. Hayden, Alan J Hay, Larisa V. Gubareva, Elena A. Govorkova, Emi Takashita, Jennifer L. McKimm‐Breschkin · 2021 · Antiviral Research
31. Structural, Energetic, and Dynamic Aspects of Ligand–Receptor Interactions
    Domantas Motiejunas, Rebecca C. Wade · 2007 · Elsevier eBooks
32. Novel Neuraminidase Inhibitors: Identification, Biological Evaluation and Investigations of the Binding Mode
    Johannes Kirchmair, Judith Maria Rollinger, Klaus Roman Liedl, Nora Seidel, Andi Krumbholz, Michaela Schmidtke · 2011 · Future Medicinal Chemistry
33. Characterization of compounds and potential neuraminidase inhibitors from the n-butanol extract of Compound Indigowoad Root Granule using ultrafiltration and liquid chromatography–tandem mass spectrometry
    Shu Liu, Jun Yan, Junpeng Xing, Fengrui Song, Zhiqiang Liu, Shuying Liu · 2011 · Journal of Pharmaceutical and Biomedical Analysis
34. Enantioselective Total Synthesis of (+)‐Stachyflin: A Potential Anti‐Influenza A Virus Agent Isolated from a Microorganism
    Junji Sakurai, Takuya Kikuchi, Ohgi Takahashi, Kazuhiro Watanabe, Tadashi Katoh · 2011 · European Journal of Organic Chemistry
35. The Role of Functional Groups in Drug–Receptor Interactions
    Laurent Schaeffer · 2008 · Elsevier eBooks
36. Synthesis of Highly Functionalized Piperidines via One-Pot, Five-Component Reactions in the Presence of Acetic Acid Solvent
    Mojtaba Lashkari, Malek Taher Maghsoodlou, Nourallah Hazeri, Sayyed Mostafa Habibi‐Khorassani, Seyed Sajad Sajadikhah, Razieh Doostmohammadi · 2012 · Synthetic Communications
37. Recent development in the design of sialyltransferase inhibitors
    Xiaofang Wang, Lihe Zhang, Xin‐Shan Ye · 2002 · Medicinal Research Reviews
38. Strategies for Antiviral Drug Discovery
    PS Jones · 1998 · Antiviral chemistry & chemotherapy
39. The Role of Medical Structural Genomics in Discovering New Drugs for Infectious Diseases
    Wesley C. Van Voorhis A, Wim G. J. Hol, Peter John Myler, Lance J. Stewart · 2009 · PLoS Computational Biology
40. Neuraminidase inhibitors for the treatment and prevention of influenza
    Jennifer L. McKimm‐Breschkin · 2002 · Expert Opinion on Pharmacotherapy
41. Exaggerated levothyroxine malabsorption due to calcium carbonate supplementation in gastrointestinal disorders
    Csako, Gyorgy, McGriff, Nayahmka J, Rotman-Pikielny, Pnina, Sarlis, Nicholas J, Pucino, Frank · 2001 · Annals of Pharmacotherapy
42. Oseltamivir Analogues Bearing N-Substituted Guanidines as Potent Neuraminidase Inhibitors
    Caitlin A. Mooney, Stuart A. Johnson, Peter ‘t Hart, Linda Quarles van Ufford, Cornelis A. M. de Haan, Ed E. Moret, Nathaniel I. Martin · 2014 · Journal of Medicinal Chemistry
43. Mutation-Induced Loop Opening and Energetics for Binding of Tamiflu to Influenza N8 Neuraminidase
    Parimal Kar, Volker Knecht · 2012 · The Journal of Physical Chemistry B
44. Comparable Fitness and Transmissibility between Oseltamivir-Resistant Pandemic 2009 and Seasonal H1N1 Influenza Viruses with the H275Y Neuraminidase Mutation
    Diana Wong, Ka-Tim Choy, Renee W. Y. Chan, Sin Fun Sia, Hsin-Ping Chiu, Peter Pak‐Hang Cheung, Michael C. W. Chan, Malik J. S. Peiris, Hui‐Ling Yen · 2012 · Journal of Virology
45. Structure-Based Tetravalent Zanamivir with Potent Inhibitory Activity against Drug-Resistant Influenza Viruses
    Lifeng Fu, Yuhai Bi, Yan Wu, Shanshan Zhang, Jianxun Qi, Yan Li, Xuancheng Lu, Zhen‐Ning Zhang, Xun Lv, Jinghua Yan et al. · 2016 · Journal of Medicinal Chemistry
46. Sialyltransferase Inhibitors for the Treatment of Cancer Metastasis: Current Challenges and Future Perspectives
    Ser John Lynon P. Perez, Chih‐Wei Fu, Wen‐Shan Li · 2021 · Molecules
47. Modeling human influenza infection in the laboratory
    Kathryn A. Radigan, Scott Budinger, Alexander V. Misharin, Monica Chi · 2015 · Infection and Drug Resistance
48. Synthesis of C-5 Analogs of N-Acetylneuraminic Acid via Indium-Mediated Allylation of N-Substituted 2-Amino-2-deoxymannoses
    Seok Ki Choi, Shelly Lee, George M. Whitesides · 1996 · The Journal of Organic Chemistry
49. The conformation of an inhibitor bound to the gastric proton pump
    David A. Middleton, Rachel Robins, Xiao‐Long Feng, Malcolm H. Levitt, Ian D. Spiers, Carl H. Schwalbe, David G. Reid, Anthony Watts · 1997 · FEBS Letters
50. Synthesis of Phosphonic Acid Analogues of Sialic Acids (Neu5Ac and KDN) as Potential Sialidase Inhibitors
    Tak Hang Chan, Yan‐Chao Xin, Mark von Itzstein · 1997 · The Journal of Organic Chemistry
51. Zanamivir
    Susan M. Cheer, Antona J. Wagstaff · 2002 · Drugs
52. Structural genomics: opportunities and challenges
    Peer R. E. Mittl, Markus G. Grütter · 2001 · Current Opinion in Chemical Biology
53. Oral Administration of Cyclopentane Neuraminidase Inhibitors Protects Ferrets against Influenza Virus Infection
    Clive Sweet, K. J. Jakeman, Karen Bush, Pamela C. Wagaman, Linda A. McKown, Anthony J. Streeter, Daksha Desai‐Krieger, Pooran Chand, Yarlagadda S. Babu · 2002 · Antimicrobial Agents and Chemotherapy
54. Synthesis and biological evaluation of sulfur isosters of the potent influenza virus sialidase inhibitors 4-amino-4-deoxy- and 4-deoxy-4-guanidino-Neu5Ac2en
    Gaik B. Kok, Michael Campbell, Brendan L. Mackey, Mark von Itzstein · 1996 · Journal of the Chemical Society Perkin Transactions 1
55. Mucin-like Region of Herpes Simplex Virus Type 1 Attachment Protein Glycoprotein C (gC) Modulates the Virus-Glycosaminoglycan Interaction
    Noomi Altgärde, Charlotta E. Eriksson, Nadia Peerboom, Tuan Phan-Xuan, Stephanie J. Moeller, Matthias Schnabelrauch, Sofia Svedhem, Edward Trybala, Tomas B. Bergström, Marta Bally · 2015 · Journal of Biological Chemistry
56. Unusual Influenza A Viruses in Bats
    Andrew Mehle · 2014 · Viruses
57. Tuning Mechanism‐Based Inactivators of Neuraminidases: Mechanistic and Structural Insights
    Buchini, Sabrina, Gallat, François‐Xavier, Greig, Ian R., Kim, Jin‐Hyo, Wakatsuki, Soichi, Chavas, Leonard M. G., Withers, Stephen G. · 2014 · Angewandte Chemie International Edition
58. A Balance between Inhibitor Binding and Substrate Processing Confers Influenza Drug Resistance
    Li Jiang, Ping Liu, Claudia Bank, Nicholas Renzette, Kristina Prachanronarong, Lutfu Safak Yilmaz, Daniel R. Caffrey, Konstantin B. Zeldovich, Celia A. Schiffer, Timothy F. Kowalik et al. · 2015 · Journal of Molecular Biology
59. Structure-based drug discovery for combating influenza virus by targeting the PA–PB1 interaction
    Ken Watanabe, Takeshi Ishikawa, Hiroki Otaki, Satoshi Mizuta, Tsuyoshi Hamada, Takehiro Nakagaki, Daisuke Ishibashi, Shuzo Urata, Jiro Yasuda, Yoshimasa Tanaka et al. · 2017 · Scientific Reports
60. Development of N‐acetylneuraminic acid responsive biosensors based on the transcriptional regulator NanR
    Gert Peters, Brecht De Paepe, Lien De Wannemaeker, Dries Duchi, Jo Maertens, Jeroen Lammertyn, Marjan De Mey · 2018 · Biotechnology and Bioengineering
61. Correlation Analyses on Binding Affinity of Sialic Acid Analogues with Influenza Virus Neuraminidase-1 Using ab Initio MO Calculations on Their Complex Structures
    Seiji Hitaoka, Masataka Harada, Tatsusada Yoshida, Hiroshi Chuman · 2010 · Journal of Chemical Information and Modeling
62. Structure of glyceraldehyde-3-phosphate dehydrogenase fromPlasmodium falciparum
    Jacqueline F. Satchell, Robyn L. Malby, Cindy S. Luo, Akinola Adisa, Aysun E. Alpyurek, Nectarios Klonis, Brian James Smith, Leann M. Tilley, Peter M. Colman · 2005 · Acta Crystallographica Section D Biological Crystallography
63. Thiosialoside clusters using carbosilane dendrimer core scaffolds as a new class of influenza neuraminidase inhibitors
    Jun-Ichi Sakamoto, Tetsuo Koyama, Daisei Miyamoto, Sangchai Yingsakmongkon, Kazuya I.P.J. Hidari, Wipawee Jampangern, Takashi Suzuki, Yasuo Suzuki, Yasuaki Esumi, Ken Hatano et al. · 2006 · Bioorganic & Medicinal Chemistry Letters
64. Coupled bioconversion for preparation of N-acetyl-d-neuraminic acid using immobilized N-acetyl-d-glucosamine-2-epimerase and N-acetyl-d-neuraminic acid lyase
    Shiyuan Hu, Jun Chen, Zhongyi Yang, Lijun Shao, Hua Bai, Jiali Luo, Weihong Jiang, Yunliu Yang · 2009 · Applied Microbiology and Biotechnology
65. Human sialidase inhibitors: Design, synthesis, and biological evaluation of 4-acetamido-5-acylamido-2-fluoro benzoic acids
    Sadagopan Magesh, Vats Savita, Setsuko Moriya, Tohru Suzuki, Taeko Miyagi, Hideharu Ishida, Makoto Kiso · 2009 · Bioorganic & Medicinal Chemistry
66. Real Time Enzyme Inhibition Assays Provide Insights into Differences in Binding of Neuraminidase Inhibitors to Wild Type and Mutant Influenza Viruses
    Susan Barrett, Peter G. Mohr, Peter M. Schmidt, Jennifer L. McKimm‐Breschkin · 2011 · PLoS ONE
67. The Fight against the Influenza A Virus H1N1: Synthesis, Molecular Modeling, and Biological Evaluation of Benzofurazan Derivatives as Viral RNA Polymerase Inhibitors
    Mafalda Pagano, Daniele Castagnolo, Martina Bernardini, Anna Lucia Fallacara, Ilaria Laurenzana, Davide Deodato, Ulrich Kessler, Beatrice Pilger, Lilli Stergiou, Stephan Strunze et al. · 2013 · ChemMedChem
68. A Rigid Bicyclic Platform for the Generation of Conformationally Locked Neuraminidase Inhibitors
    Michael G. Brant, Jeremy E. Wulff · 2012 · Organic Letters
69. Protein structure and computational drug discovery
    Tracy L. Nero, Michael W. Parker, Craig J. Morton · 2018 · Biochemical Society Transactions
70. Post-Glycosylation Modification of Sialic Acid and Its Role in Virus Pathogenesis
    Simon Jigwan Park · 2019 · Vaccines
71. Influenza Viruses: Harnessing the Crucial Role of the M2 Ion-Channel and Neuraminidase toward Inhibitor Design
    Sphamandla E. Mtambo, Daniel Gyamfi Amoako, Anou Moise Somboro, Clement Agoni, Monsurat M. Lawal, Nelisiwe S. Gumede, Rene Bernadette Khan, Hezekiel Mathambo Kumalo · 2021 · Molecules
72. Zanamivir: from drug design to the clinic
    Michael J. Elliott · 2001 · Philosophical Transactions of the Royal Society B Biological Sciences
73. Prophylaxis and Treatment of Influenza Virus Infection
    Ruth Kandel, Kevan L. Hartshorn · 2001 · BioDrugs
74. A structural and energetics analysis of the binding of a series of N-acetylneuraminic-acid-based inhibitors to influenza virus sialidase
    Neil R. Taylor, Mark von Itzstein · 1996 · Journal of Computer-Aided Molecular Design
75. Current Issues in De Novo Molecular Design
    David E. Clark, Christopher W. Murray, Jin Li · 1997 · Reviews in computational chemistry
76. Antiviral options and therapeutics against influenza: history, latest developments and future prospects
    Clement Adebajo Meseko, Melvin Sanicas, Kumari Asha, Lanre Sulaiman, Binod Kumar · 2023 · Frontiers in Cellular and Infection Microbiology
77. Synthetic oligosaccharides as active pharmaceutical ingredients: Lessons learned from the full synthesis of one heparin derivative on a large scale
    Pierre‐Alexandre Driguez, Pierre Potier, Patrick Trouilleux · 2014 · Natural Product Reports
78. Recent Development in Synthetic Strategies for Oseltamivir Phosphate
    Masakatsu Shibasaki, Motomu Kanai, Kenzo Yamatsugu · 2011 · Israel Journal of Chemistry
79. Structural basis for a class of nanomolar influenza A neuraminidase inhibitors
    Philip S. Kerry, Sankar Mohan, Rupert J. M. Russell, Nicole Bance, Masahiro Niikura, Bernardine M. Pinto · 2013 · Scientific Reports
80. Organocatalytic Michael Reaction of Nitroenamine Derivatives with Aldehydes: Short and Efficient Asymmetric Synthesis of (−)‐Oseltamivir
    Jiang Weng, Yong‐Bo Li, Rui‐Bin Wang, Gui Lu · 2012 · ChemCatChem
81. Coupling the Petasis Condensation to an Iron(III) Chloride-Promoted Cascade Provides a Short Synthesis of Relenza Congeners
    Jean‐François Soulé, Aurélie Mathieu, Stéphanie Norsikian, Jean‐Marie Beau · 2010 · Organic Letters
82. New antiviral approaches for human parainfluenza: Inhibiting the haemagglutinin-neuraminidase
    Vimbaishe P. Chibanga, Larissa Dirr, Patrice Guillon, Ibrahim Mustafa El-Deeb, Benjamin Bailly, Robin J. Thomson, Mark von Itzstein · 2019 · Antiviral Research
83. Design, synthesis of oleanolic acid-saccharide conjugates using click chemistry methodology and study of their anti-influenza activity
    Yangqing Su, Lingkuan Meng, Jiaqi Sun, Weijia Li, Liang Shao, Kexuan Chen, Demin Zhou, Fan Yang, Fei Yu · 2019 · European Journal of Medicinal Chemistry
84. CONFIRM: connecting fragments found in receptor molecules
    David C. Thompson, R. Aldrin Denny, Ramaswamy Nilakantan, Christine C. Humblet, Diane Joseph‐McCarthy, Eric Feyfant · 2008 · Journal of Computer-Aided Molecular Design
85. Molecular dynamics simulations of bovine rhodopsin: influence of protonation states and different membrane-mimicking environments
    Birgit Schlegel, Wolfgang Sippl, Hans‐Dieter Höltje · 2005 · Journal of Molecular Modeling
86. Two Trans-sialidase Forms with Different Sialic Acid Transfer and Sialidase Activities from Trypanosoma congolense
    Evelin Tiralongo, Silke Schrader, Hans Lange, Hilmar Lemke, Joe Tiralongo, Roland Schauer · 2003 · Journal of Biological Chemistry
87. Lipidation and glycosylation of a T cell antigen receptor (TCR) transmembrane hydrophobic peptide dramatically enhances in vitro and in vivo function
    Michael A. Amon, Marina Ali, Vera Bender, Yiu‐Ngok Chan, István Tóth, Nicholas Manolios · 2006 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
88. A novel approach to antiviral therapy for influenza
    Peter M. Colman · 1999 · Journal of Antimicrobial Chemotherapy
89. Guanidinobenzoic acid inhibitors of influenza virus neuraminidase 1 1Edited by R. Huber
    Elise A. Sudbeck, Marek J. Jedrzejas, Sangeeta Singh, Wayne J. Brouillette, Gillian M. Air, William Graeme Laver, Yarlagadda S. Babu, Shanta Bantia, Pooran Chand, N. Chu et al. · 1997 · Journal of Molecular Biology
90. A New Approach to Neuraminic Acid Analogues via 1,2-Oxazines
    Bettina Bressel, Hans‐Ulrich Reißig · 2008 · Organic Letters
91. Correlation Analyses on Binding Affinity of Sialic Acid Analogues and Anti-Influenza Drugs with Human Neuraminidase Using ab Initio MO Calculations on Their Complex Structures – LERE-QSAR Analysis (IV)
    Seiji Hitaoka, Hiroshi Matoba, Masataka Harada, Tatsusada Yoshida, Daisuke Tsuji, Takatsugu Hirokawa, Kohji Itoh, Hiroshi Chuman · 2011 · Journal of Chemical Information and Modeling
92. Total Synthesis of Sialic Acid by a Sequential Rhodium‐Catalyzed Aziridination and Barbier Allylation of D ‐Glycal
    Rujee Lorpitthaya, Sharad B. Suryawanshi, Siming Wang, Kalyan Kumar Pasunooti, Shuting Cai, Jimei Ma, Xue‐Wei Liu · 2011 · Angewandte Chemie International Edition
93. Potent bacterial neuraminidase inhibitors, anthraquinone glucosides from Polygonum cuspidatum and their inhibitory mechanism
    Zia Uddin, Yeong Hun Song, Marcus J. C. Long, Jeong Yoon Kim, Heung Joo Yuk, Ki Hun Park · 2016 · Journal of Ethnopharmacology
94. Inhibition of human parainfluenza virus type 1 sialidase by analogs of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid
    Takashi Suzuki, Kiyoshi Ikeda, Noriko Koyama, Chika Hosokawa, Toshihiro Kogure, Tadanobu Takahashi, Kazuya I.P.J. Hidari, Daisei Miyamoto, Kiyoshi Tanaka, Yasuo Suzuki · 2001 · Glycoconjugate Journal
95. Structure‐Based Organic Synthesis of Drug Prototypes: A Personal Odyssey
    Stephen Hanessian · 2006 · ChemMedChem
96. A QSAR study on influenza neuraminidase inhibitors
    Rajeshwar P. Verma, Corwin H. Hansch · 2005 · Bioorganic & Medicinal Chemistry
97. Binding Interaction Analysis of the Active Site and Its Inhibitors for Neuraminidase (N1 Subtype) of Human Influenza Virus by the Integration of Molecular Docking, FMO Calculation and 3D-QSAR CoMFA Modeling
    Qingye Zhang, Jiaoyan Yang, Kun Liang, Lingling Feng, Sanpin Li, Jian Wan, Xin Xu, Guang‐Fu Yang, Deli Liu, Shao Yang · 2008 · Journal of Chemical Information and Modeling
98. Two Approaches toward the Formal Total Synthesis of Oseltamivir Phosphate (Tamiflu): Catalytic Enantioselective Three-Component Reaction Strategy and l -Glutamic Acid Strategy
    Kaliyamoorthy Alagiri, Makoto Furutachi, Kenzo Yamatsugu, Naoya Kumagai, Takumi Watanabe, Masakatsu Shibasaki · 2013 · The Journal of Organic Chemistry
99. Synthesis of multivalent difluorinated zanamivir analogs as potent antiviral inhibitors
    Zhaoliang Yang, Xiong-Fei Zeng, Haipeng Liu, Qun Yu, Xin Meng, Zhong-Li Yan, Zhen‐Chuan Fan, Haixia Xiao, Suri S. Iyer, Yang Yang et al. · 2016 · Tetrahedron Letters
100. Magnetic beads-based neuraminidase enzyme microreactor as a drug discovery tool for screening inhibitors from compound libraries and fishing ligands from natural products
     Yu-Mei Zhao, Lvhuan Wang, Sifan Luo, Qiqin Wang, Ruin Moaddel, Tingting Zhang, Zhengjin Jiang · 2018 · Journal of Chromatography A